Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Forward Pharma logo — Pioneering new therapies in oncology and autoimmunity throug...

Forward Pharma

Pioneering new therapies in oncology and autoimmunity through advanced small-molecule pharmaceuticals and targeted antibody drugs.

Founded 2015 Series B Health Care, Pharmaceutical

General Information

Company Name Forward Pharma
Founded Year 2015
Industries Health Care, Pharmaceutical
Funding Stage Series B
Social

Get notified when Forward Pharma moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Forward Pharma

Forward Pharma, Pioneering new therapies in oncology and autoimmunity through advanced small-molecule pharmaceuticals and targeted antibody drugs. Established in 2015, the company is dedicated to Health Care and Pharmaceutical industries, focusing on developing innovative small-molecule pharmaceuticals and antibody-targeted drugs. Their primary focus is on discovering and advancing pioneering new treatments in the fields of oncology and autoimmunity. Forward Pharma recently received a Series B investment at 14 July 2023 from ZGC Group. This investment is a testament to the potential and promise that the company holds in revolutionizing therapies in these critical medical domains.

Taxonomy: Oncology, Autoimmunity, Pharmaceuticals, Small-molecule drugs, Antibody-targeted drugs, Research and development, Innovation, Therapies, Medications

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Series B •••••• 1 •••• •••• 14 Jul 2023

Forward Pharma Alternatives & Competitors

Forward Pharma vs
Hongjitang
Hongjitang

Crafting Health Across Generations with a Comprehensive Range of Pediatric, Gynecological, Respirato...

Post Ipo Equity
1001-5000 employees
Manufacturing, Pharmaceutical
Forward Pharma vs
Yannuo Pharmaceutical
Yannuo Pharmaceutical

Pioneering advanced therapies in oncology, contrast agents, and anesthesia through innovative drug d...

Series A
Biotechnology, Pharmaceutical
Forward Pharma vs
OBL Pharm
OBL Pharm

Delivering excellence in gastroenterology, cardiology, phlebology, and neurology care through truste...

Private Equity
Pharmaceutical

FAQ About Forward Pharma

Pioneering new therapies in oncology and autoimmunity through advanced small-molecule pharmaceuticals and targeted antibody drugs.
Forward Pharma was founded in 2015.
Forward Pharma operates in the following industries: Health Care, Pharmaceutical.
Forward Pharma has completed 1 funding round. The latest funding stage is Series B.
Top alternatives and competitors to Forward Pharma include Hongjitang, Yannuo Pharmaceutical, OBL Pharm, Oddway International, EpiDestiny. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Forward Pharma and Hongjitang are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Forward Pharma and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy